The therapeutic potential of CXCR4 antagonists in the treatment of HIV

Author： Fujii Nobutaka Nakashima Hideki Tamamura Hirokazu

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.2, 2003-02, pp. : 185-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis

By Tamamura Hirokazu Fujii Nobutaka

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1267-1282

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Antagonists of the CXCR2 and CXCR1 Chemokine Receptors as Therapeutic Agents for the Treatment of Inflammatory Diseases

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 13, 2006-01 ,pp. : 1345-1352

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Low Molecular Weight CXCR4 Antagonists by Exploratory Structural Tuning of Cyclic Tetra- and Pentapeptide-Scaffolds Towards the Treatment of HIV Infection, Cancer Metastasis and Rheumatoid Arthritis

Current Medicinal Chemistry, Vol. 14, Iss. 1, 2007-01 ,pp. : 93-102

Bentham Science Publishers

Access to resources Recommend Favorite

Small-Molecule Antagonists of CCR5 and CXCR4: A Promising New Class of Anti-HIV-1 Drugs

Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-07 ,pp. : 2041-2062

Bentham Science Publishers

Access to resources Recommend Favorite

Thrombin Receptor Antagonists for the Treatment of Atherothrombosis: Therapeutic Potential of Vorapaxar and E-5555

By Leonardi Sergio Tricoci Pierluigi Becker Richard C.

Drugs, Vol. 70, Iss. 14, 2010-10 ,pp. : 1771-1783

Adis International

Access to resources Recommend Favorite